WHO ICTRP trial
De rol van de slijmvliezen bij het ontstaan van auto-antistoffen in reumatoïde…
NL-OMON23860 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON23860 |
|---|---|
| Public title | De rol van de slijmvliezen bij het ontstaan van auto-antistoffen in reumatoïde artritis |
| Scientific title | ‘MUCosal Origin of Serum Autoantibodies in rheumatoid arthritis’ |
| Primary sponsor | No direct sponsoring of this trail |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Rheumatoid arthritis |
| Interventions | Participants will donate blood, saliva, sputum (optional) and feces once and will have to fill out an online questionnaire |
| Registration date | Jan 16, 2020 |
| Target size | 260 |
| Secondary IDs | NL8306;NL71319.058.19 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: